济南痛风病痛风病医院比较好济南痛风病人可不可以吃菜花,济南治疗痛风的医院有哪些方法,山东长痛风石不痛,济南痛风不管它自己会好吗,北京痛风需要多走吗,济南痛风石是怎么得的,山东痛风的治疗需要多少钱

As President Donald Trump and Republicans attempt to reverse the results of last week’s presidential election in Pennsylvania, a significant case often cited by Trump’s supporters has lost steam.The House Oversight Committee, led by Democratic Congresswoman Carolyn Maloney, announced that Richard Hopkins has “recanted” his claim of election fraud in Erie County, Pennsylvania. Hopkins had previously accused fellow USPS employees of changing the date of ballots submitted after the election. 501

AstraZeneca is the latest drugmaker to announce promising Phase 3 trial results from its COVID-19 vaccine candidate.On Monday, AstraZeneca said its two-shot vaccine candidate has been 90% effective thus far along with no safety concerns.“These findings show that we have an effective vaccine that will save many lives," said Professor Andrew Pollard, the chief executive of the study. Excitingly, we’ve found that one of our dosing regimens may be around 90% effective and if this dosing regime is used, more people could be vaccinated with planned vaccine supply. Today’s announcement is only possible thanks to the many volunteers in our trial, and the hard working and talented team of researchers based around the world.”The company added in its press release that its vaccine candidate offers two distinct advantages over vaccines made by Pfizer and Moderna — it's cheaper to produce, and does not need to be stored in ultra-cold conditions before use.AstraZeneca added that the company would "immediately" prepare regulatory paperwork to seek Emergency Use Listing status from the World Health Organization.AstraZeneca is just the latest drug company to report encouraging results from its COVID-19 vaccine candidate.Last week, Pfizer said it had submitted Emergency Use Authorization paperwork to the Food & Drug Administration (FDA) after a final analysis of its vaccine candidate proved to be 95% effective in preventing COVID-19. The FDA is expected to approve the drug in the coming weeks.Moderna has also said that early results show its vaccine candidate to be 95% effective, and is on track to have the drug approved for Emergency Use Authorization by the end of the year.AstraZeneca, Pfizer and Moderna are all shattering records for vaccine development. The three vaccines are all on track to be approved for widespread use in uder a year. Typically, it takes several years for a vaccine to go from development to approval.The announcement comes as COVID-19 is spreading around the world at a rate not previously seen since the pandemic began. And while all three companies are pre-producing their vaccines in the hope that it will be approved, health experts warn that they won't be widely available until spring 2021. 2247

ATLANTA, Ga. – Former Republican presidential candidate Herman Cain has been hospitalized after being diagnosed with COVID-19.Cain’s staff announced on Thursday that the 74-year-old businessman was informed on Monday that he had contracted the coronavirus.By Wednesday, Cain had developed symptoms serious enough that he required hospitalization and he was admitted into an Atlanta-area hospital, according to a statement.As of Thursday, staff says Cain is resting comfortably, he is awake and alert, and hasn’t yet required a respirator.“There is no way of knowing for sure how or where Mr. Cain contracted the coronavirus, but we don’t know he is a fighter who has beaten Stage 4 cancer,” the statement reads. “With God’s help, we are confident he will make a quick and complete recovery…”We are sorry to announce that Herman Cain has tested positive for COVID-19, and is currently receiving treatment in an Atlanta-area hospital. Please keep him, and all who are battling this virus, in your prayers.Our full statement appears below. Updates to follow. pic.twitter.com/lDRW7Rla4e— Herman Cain (@THEHermanCain) July 2, 2020 Cain recently attended President Donald Trump’s campaign rally in Tulsa, Oklahoma. He tweeted a photo from the June 20 event.Here’s just a few of the #BlackVoicesForTrump at tonight’s rally! Having a fantastic time!#TulsaRally2020 #Trumptulsa #TulsaTrumprally #MAGA #Trump2020 #Trump2020Landslide pic.twitter.com/27mUzkg7kL— Herman Cain (@THEHermanCain) June 20, 2020 1502

As Republicans absorb the shock of losing the House of Representatives, the GOP leadership race in the chamber is ramping up to determine who will take over the position of No. 1 House Republican after outgoing House Speaker Paul Ryan leaves.Rep. Jim Jordan, the co-founder of the conservative House Freedom Caucus, announced a bid for minority leader on Wednesday, setting up a challenge to Rep. Kevin McCarthy, the current No. 2 Republican and House majority leader, who is viewed as the favorite to succeed Ryan."I think we have to match the President's intensity on changing this town as we move forward," Jordan told CNN on Wednesday when asked about his bid for minority leader and a challenge to McCarthy.Asked about how House Republicans can counter a Democratic majority pursuing oversight of the President and the administration, Jordan said, "You stand up for the truth. You stand up and defend the White House and the President." He added that Republicans will have to "show the American people the difference in where we would like to take the country and earn back their trust and earn back the majority."According to a source familiar with his plans, Jordan is expected to make the pitch that Republicans would need a fierce attack dog as minority leader to fight against Democrat oversight efforts, and Jordan has already proven he has a loud and aggressive bark.House Republicans are set to hold their leadership elections on Wednesday of next week, a day after they return to Washington.McCarthy has yet to formally announce his own bid for minority leader. Jordan, meanwhile, is viewed as a long shot for the House GOP leadership post.It's unclear yet if House Majority Whip Steve Scalise could also mount a bid for minority leader.Scalise has said that he would not challenge McCarthy in a race for speaker, but when asked recently whether he would challenge the current No. 2 Republican in a race for minority leader if Republicans lost the House, he declined to speculate on the hypothetical."I've never been in the speculation game," Scalise told Roll Call, adding, "when Paul said he was going to step down — I said I'd support Kevin. And I haven't talked about all the things that might happen and what I might run for."With House Republicans in the minority, there may be a match-up between Rep. Cathy McMorris Rodgers and Rep. Liz Cheney for the position of GOP conference chair. McMorris Rodgers currently holds that position, but Cheney on Wednesday formally announced her candidacy for the spot in the next Congress."I am asking for your support to be House Republican Conference Chair because I know we can and must prevail, and I want to lead the effort to build a new and effective House GOP communications operation," Cheney wrote in a letter to members on Wednesday.McMorris Rodgers has not yet announced what she plans to do.Republican Study Committee Chairman Mark Walker will run for GOP conference vice chair.Walker was contacting his colleagues Wednesday morning and letting them know he is running, according to his spokesman, Jack Minor. 3087

At least three people were killed and a dozen others injured Tuesday after gunfire erupted near a Christmas market in the center of the French city of Strasbourg, French authorities said.Strasbourg police said an armed person entered the perimeter of the Christmas market by the Corbeau Bridge around 8 p.m., heading toward the Rue des Orfèvres. The suspect then opened fire, police said. Police said they have identified the shooter, who remains at large.Here are the latest developments: 497